Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology, ELUTYX™$1. .$1
ocular drug delivery • surgical sealants • sustained delivery • ophthalmic therapies • ophthalmology
51 - 200
November 7
51 - 200
Manage projects for a biopharmaceutical company focusing on eye diseases.
October 20
51 - 200
Assist in clinical project management for Ocular Therapeutix's drug delivery solutions.
October 20
51 - 200
Lead GCP quality assurance for Ocular Therapeutix's clinical trials.